| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -53.8% |
| Cost of Revenue | $2.1M | -53.9% |
| Gross Profit | -$538K | +54.3% |
| R&D Expense | $334K | -22.0% |
| SG&A Expense | $3.9M | -18.6% |
| Operating Income | -$5.1M | +27.8% |
| Interest Expense | $1.1M | — |
| Pre-tax Income | -$5.5M | +22.9% |
| Income Tax | $236 |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142K | -55.7% |
| Accounts Receivable | $501K | -31.8% |
| Inventory | $204K | +48.5% |
| Current Assets | $4.3M | -17.2% |
| Total Assets | $12.9M | -19.8% |
| Current Liabilities | $28.6M | +341.2% |
| Long-term Debt | $2.9M | -90.6% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +40.9% |
| Investing Cash Flow | -$52K | +93.8% |
| Financing Cash Flow | $1.7M | -58.3% |
| +0.0% |
| Net Income | -$5.3M | +21.8% |
| EPS (Basic) | -$1.00 | -3233.3% |
| EPS (Diluted) | -$1.00 | -3233.3% |
| Total Liabilities |
| $31.6M |
| -16.4% |
| Stockholders' Equity | -$18.7M | +11.0% |